Company Performance Metrics
- Carey-Ann Burnham: Incoming Chief Clinical Officer
- Bryan Gammon: DirectorPast Role: Luminous Dermatology, Co-Founder and President
Pattern Bioscience is a privately held in vitro diagnostics company founded in 2016 to help combat the problem of antibiotic resistance. The pattern is developing a next-generation clinical microbiology platform based on its patented phenotypic single-cell technology that can identify pathogens and determine their antibiotic response without the
need for traditional time-consuming culture steps.
Pattern’s Digital CultureTM technology relies on functional endpoints that encompass all possible resistance mechanisms, resulting in a more comprehensive and reliable diagnosis compared to rapid genotypic tests. The platform will deliver more reliable diagnoses days faster than the current standard of care.